ArticleJournal of clinical pathology2019

Feasibility of combined screening for upper gastrointestinal adenocarcinoma risk by serology and Cytosponge testing: the SUGAR study.

Yiwang Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.